Univercells is a one-stop-shop for end-to-end high-density low-cost biomanufacturing solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Its technologies, aimed at low-cost manufacturing of antibodies, proteins and vaccines, is based on single-use technologies and chaining of three manufacturing steps into simulated continuous mode: cell culture under perfusion, clarification and capture.

Visite el sitio web de Univercells

Univercells colaboradores

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2023 World Economic Forum

Política de privacidad y normas de uso